PURE Bioscience, Inc. (PURE) Operating cash flow 2017–2026
PURE Bioscience, Inc. (PURE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.7MFY2026 · since FY2017: -$4.6M → -$1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.7M | +13.7% |
| FY2025 | -$2.0M | +20.4% |
| FY2024 | -$2.5M | +22.8% |
| FY2023 | -$3.3M | -35.6% |
| FY2022 | -$2.4M | -107.2% |
| FY2021 | -$1.2M | -274.4% |
| FY2020 | $669,000 | +122.4% |
| FY2019 | -$3.0M | +23.1% |
| FY2018 | -$3.9M | +14.8% |
| FY2017 | -$4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Net marginPURE Gross profitPURE Gross marginPURE Operating incomePURE Operating marginPURE Free cash flowPURE Capital expendituresPURE Return on equityPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Total liabilitiesPURE Shareholders’ equityPURE overview →